DiaMedica Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

DiaMedica Therapeutics

05/05/2022 23:01

* DiaMedica Therapeutics Inc  DMAC.OQ  reported a quarterly
adjusted loss of 13 cents​​ per share for the quarter ended in
March. The mean expectation of four analysts for the quarter was
for a loss of 21 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * DiaMedica Therapeutics Inc's reported EPS for the quarter
was a
loss of 13 cents​.
    * The mean earnings estimate of analysts had risen by
about 7.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * DiaMedica Therapeutics Inc shares had fallen by 0.8% this
quarter and lost 33.5% so far this year.
    * The company reported a quarterly loss of $3.51 million.
    * Wall Street's median 12-month price target for DiaMedica
Therapeutics Inc is $15.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 5 at 10:01 p.m.  ​All
figures in US dollars unless otherwise stated